Certainty in the Ever-Changing Pharmacovigilance Landscape

Managing the safety risks of your medical therapies/products is critical throughout the duration of their lifecycle. We provide you with the certainty that your pharmacovigilance needs are being addressed in a comprehensive and proficient manner.


Veristat supports successful pre-approval and post-market pharmacovigilance (PV) and Medical Information (MI) expertise for pharmaceutical drugs (brand and generic), biologics, radiopharmaceutical drugs, natural health products, and medical devices.

With the acquisition of SFL (Solutions for Life Sciences), Veristat expands its Pharmacovigilance expertise into Europe.

Tailored PV Solutions to Reduce Risk

Our team of highly dedicated and experience PV professionals ensures the fulfillment of your regulatory requirements through sound processes and efficient systems.

Learn More with These Resources

Fact Sheet

Pharmacovigilance Trusted Partner

Fact Sheet

Pharmacovigilance Key Stats Fact Sheet

Webinar Video Replay

What's New in Draft MHPD Guidance on Reporting Adverse ...